FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 74 filers reported holding FATE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $147 | -99.9% | 14,594 | +15.2% | 0.02% | -26.9% |
Q3 2022 | $284,000 | -70.7% | 12,673 | +7.8% | 0.03% | -62.3% |
Q1 2021 | $970,000 | +502.5% | 11,759 | -28.8% | 0.07% | +666.7% |
Q1 2018 | $161,000 | +43.8% | 16,521 | -9.5% | 0.01% | +50.0% |
Q4 2017 | $112,000 | +53.4% | 18,251 | -1.3% | 0.01% | +50.0% |
Q3 2017 | $73,000 | – | 18,493 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 716,392 | $11,126,000 | 12.18% |
Polaris Venture Management Co. V, L.L.C. | 1,139,783 | $17,701,000 | 10.06% |
Grosvenor Holdings, L.L.C. | 2,285,714 | $35,497,000 | 6.41% |
Redmile Group, LLC | 11,216,809 | $174,197,000 | 5.83% |
Casdin Capital, LLC | 2,550,000 | $39,601,500,000 | 4.10% |
DAFNA Capital Management LLC | 470,000 | $7,299,000 | 2.74% |
Ghost Tree Capital, LLC | 350,000 | $5,436,000 | 1.38% |
Artal Group S.A. | 2,000,000 | $31,060,000 | 1.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,952,897 | $30,328,000 | 1.24% |
Copernicus Capital Management, LLC | 75,000 | $1,165,000 | 1.08% |